Industry reports
September_New Drugs｜CAR-T Cell Drugs: A Promising Trend
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
CAR-T therapy breaks new ground, sets record for longest remission period ...read more
August_Medical Technology｜Telemedicine Technology Business Opportunities in Telemedicine
Diversified choices of pathways to see the doctor, now you don't have to go to the clinic to see the doctor! The COVID-19 epidemic is an important driver of zero-contact telemedicine, which breaks the mold of past patient and doctor visits. ...read more
July_New Drugs｜Alzheimer's Disease Diagnostics and New Drug Opportunities Ready for Development
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Dementia is one of the greatest challenges to an aging society, and the fight against dementia is one of the most urgent and unmet medical needs of humanity worldwide. ...read more
May_CDMO Topics｜Asia CDMOs are back with new opportunities
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Global Biotech CDMO (Contract Development and Marketing Organization) ...read more
April_Tariff War｜Tariff War Extends, Drugs Become New Concerns
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
Under Trump's reciprocal tariffs, medical devices and equipment have been victimized and included in the scope of tariff increase, which is a direct hit. ...read more
April_Tariff War｜U.S. reciprocal tariffs hit the global biotech and pharmaceutical industry, and the industry is "crapping its pants".
Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute
The U.S. is wielding the tariff stick again, and on 4/2 Trump signed an executive order on "reciprocal tariffs", imposing more than 180 tariffs on more than 180 countries worldwide. ...read more
March_Special Topics｜Changes in the U.S. Pharmaceutical Industry under the Trump Administration
U.S. government spending cuts are shaking up the broader U.S. healthcare ecosystem, seemingly announcing that the era of abundant U.S. healthcare funding is over, and whether or not it will embark on an environment of pharmaceutical austerity remains to be seen, but optimization and refinement of the ...read more
January_CES 2025 Immersed in GAI+AI, Continuously Accelerating Innovation and Development in the Digital Health Industry (Next)
Brain Neurotronics enhances mental health, allowing for a wider range of brain health technology applications.
Under AARP Agetech 2 ...read more
